DOXORUBICIN TEVA Adverse Event: Hepatocellular injury
DOXORUBICIN TEVA Adverse Event: Hepatocellular injury is one of 4,500 adverse events in the FDATracker dataset. Key details — Primary drug: DOXORUBICIN TEVA; Product category: Drug; Primary reaction: Hepatocellular injury.
| Primary drug | DOXORUBICIN TEVA |
|---|---|
| Product category | Drug |
| Primary reaction | Hepatocellular injury |
| All reactions | Hepatocellular injury; Cholestasis; Pyrexia |
| Seriousness | Serious |
| Patient outcome | Recovering/Resolving |
| Patient sex | Female |
| All drugs reported | DOXORUBICIN TEVA; MABTHERA; ONCOVIN; ENDOXAN |
| Reporter country | FR |
| Reporter type | 3 |
| Report date | 20140312 |
| Report ID | 10003955 |
$299/mo
Try FDATracker →